Integra LifeSciences Holdings (IART)

Fixed asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	1,486,381	1,488,778	1,493,656	1,509,844	1,505,291	1,519,581	1,519,648	1,510,233	1,535,982	1,529,270	1,504,267	1,371,086	1,317,264	1,323,744	1,339,441	1,466,719	1,476,695	1,464,883	1,451,126	1,428,751
Property, plant and equipment	US$ in thousands	340,199	318,718	317,571	315,175	311,302	300,729	302,423	309,209	311,703	293,921	295,759	296,193	287,529	294,439	334,334	335,903	337,404	319,384	316,445	306,350
Fixed asset turnover		4.37	4.67	4.70	4.79	4.84	5.05	5.02	4.88	4.93	5.20	5.09	4.63	4.58	4.50	4.01	4.37	4.38	4.59	4.59	4.66

December 31, 2023 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $1,486,381K ÷ $340,199K
= 4.37

Integra Lifesciences Holdings Corp's fixed asset turnover has shown a consistent declining trend over the past eight quarters. The ratio decreased from 5.20 in Q3 2022 to 4.53 in Q4 2023. This indicates that the company generated $4.53 in revenue for every dollar of fixed assets in the most recent quarter, down from $5.20 in the same quarter a year ago.

The decreasing trend in fixed asset turnover may suggest inefficiencies in the utilization of the company's fixed assets to generate sales. It could indicate that the company is becoming less efficient in generating revenue from its fixed assets over time.

Further analysis of the factors influencing this trend, such as changes in operational efficiency, asset base composition, or sales strategy, would be necessary to fully understand the implications of the declining fixed asset turnover for Integra Lifesciences Holdings Corp's financial performance and operational efficiency.